Neil Josephson - Jul 5, 2022 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Chief Medical Officer
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Jul 5, 2022
Transactions value $
$6,878
Form type
4
Date filed
7/5/2022, 09:00 PM
Previous filing
Mar 11, 2022
Next filing
Nov 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYME Common Shares Award $6.88K +1.53K +16.03% $4.51 11K Jul 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period January 1, 2022 through June 30, 2022. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the Issuer's common shares on June 30, 2022.